When Is a Diagnosis of Sclerosing Adenosis Acceptable at Core Biopsy?

Published Online:https://doi.org/10.1148/radiol.2281020447

PURPOSE: To determine concordance of imaging findings and diagnosis of sclerosing adenosis at histopathologic core biopsy and to establish the accuracy of core biopsy when cancer was coexistent.

MATERIALS AND METHODS: From a database of 1,166 percutaneous biopsies in which sclerosing adenosis was reported, 88 (7.5%) lesions were identified, and imaging and histopathologic findings were reviewed for concordance. Sclerosing adenosis proved to be a minor component at core biopsy for 44 lesions, including one invasive ductal carcinoma, one ductal carcinoma in situ (DCIS), one focus of atypical ductal hyperplasia (ADH), and one atypical lobular hyperplasia. Sclerosing adenosis was a major (≥50%) component for 44 lesions, including four malignancies, all DCIS manifested as clustered calcifications (pleomorphic [n = 2] or amorphous [n = 2]), and seven foci of ADH manifested as amorphous calcifications. In 30 patients with 33 lesions without atypia or malignancy, sclerosing adenosis was the major finding at core biopsy (21 lesions at 14-gauge core biopsy and 12 at 11-gauge vacuum-assisted biopsy); these patients formed the study population. Mammographic (33 lesions) and sonographic (18 lesions) features were recorded. Twenty-seven lesions had at least 20-month follow-up (n = 25) or excision (n = 2).

RESULTS: One spiculated mass was considered discordant and was excised, showing a prospectively unrecognized radial sclerosing lesion with several 2–5-mm foci of invasive tubular and lobular carcinoma. Seventeen (53%) of 32 lesions manifested as masses; 10 (59%) were circumscribed, five (29%) were indistinctly marginated (one with punctate calcifications), and two (12%) were partially circumscribed and partially obscured (one with amorphous calcifications). Fifteen (47%) lesions manifested as clustered calcifications; nine (60%) were amorphous and indistinct, four (27%) were pleomorphic, and two (13%) were punctate. Of 27 lesions with acceptable follow-up, 26 (96%) were believed to have been accurately sampled at core biopsy. Of six radial sclerosing lesions associated with the original 88 lesions, only three (50%) were prospectively recognized.

CONCLUSION: Sclerosing adenosis is an acceptable result at core biopsy of circumscribed masses and nonpalpable indistinctly marginated masses and for clustered amorphous, pleomorphic, and punctate calcifications. Recognition and reporting of coexistent radial sclerosing lesions is encouraged and may prompt excision. Malignancy can be seen with sclerosing adenosis; core biopsy was accurate in six (86%) of seven coexistent malignancies in this series.

© RSNA, 2003

References

  • 1 Nielsen BB. Adenosis tumour of the breast: a clinicopathological investigation of 27 cases. Histopathology 1987; 11:1259-1275. Crossref, MedlineGoogle Scholar
  • 2 Foote F, Jr, Stewart F. Comparative studies of cancerous vs non-cancerous breasts. Ann Surg 1945; 12:6-53. Google Scholar
  • 3 Hughes LE, Mansel RE, Webster DJ. Aberrations of normal development and involution (ANDI): a new perspective on pathogenesis and nomenclature of benign breast disorders. Lancet 1987; 2:1316-1319. MedlineGoogle Scholar
  • 4 Taylor HB, Norris HJ. Epithelial invasion of nerves in benign diseases of the breast. Cancer 1967; 20:2245-2249. Crossref, MedlineGoogle Scholar
  • 5 MacErlean DP, Nathan BE. Calcification in sclerosing adenosis simulating malignant breast calcification. Br J Radiol 1972; 45:944-945. Crossref, MedlineGoogle Scholar
  • 6 DiPiro PJ, Gulizia JA, Lester SC, Meyer JE. Mammographic and sonographic appearances of nodular adenosis. AJR Am J Roentgenol 2000; 175:31-34. Crossref, MedlineGoogle Scholar
  • 7 Berg WA, Jaeger B, Campassi C, Kumar D. Predictive value of specimen radiography for core needle biopsy of noncalcified breast masses. AJR Am J Roentgenol 1998; 171:1671-1678. Crossref, MedlineGoogle Scholar
  • 8 American College of Radiology. Illustrated Breast Imaging Reporting and Data System (BI-RADS) 3rd ed. Reston, Va: American College of Radiology, 1998. Google Scholar
  • 9 Mendelson EB, Berg WA, Merritt CR. Toward a standardized breast ultrasound lexicon, BI-RADS: ultrasound. Semin Roentgenol 2001; 36:217-225. Crossref, MedlineGoogle Scholar
  • 10 Sloane JP, Mayers MM. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology 1993; 23:225-231. Crossref, MedlineGoogle Scholar
  • 11 Frouge C, Tristant H, Guinebretiere JM, et al. Mammographic lesions suggestive of radial scars: microscopic findings in 40 cases. Radiology 1995; 195:623-625. LinkGoogle Scholar
  • 12 Jensen RA, Page DL, Dupont WD, Rogers LW. Invasive breast cancer risk in women with sclerosing adenosis. Cancer 1989; 64:1977-1983. Crossref, MedlineGoogle Scholar
  • 13 Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TG. Prognostic significance of benign proliferative breast disease. Cancer 1993; 71:3896-3907. Crossref, MedlineGoogle Scholar
  • 14 Tavassoli FA, Norris HJ. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990; 65:518-529. Crossref, MedlineGoogle Scholar
  • 15 Shoker BS, Jarvis C, Clarke RB, et al. Abnormal regulation of the oestrogen receptor in benign breast lesions. J Clin Pathol 2000; 53:778-783. Crossref, MedlineGoogle Scholar
  • 16 Cahn MD, Tran T, Theur CP, Butler JA. Hormone replacement therapy and the risk of breast lesions that predispose to cancer. Am Surg 1997; 63:858-860. MedlineGoogle Scholar
  • 17 Westenend PJ, Liem SJ. Adenosis tumor of the breast containing ductal carcinoma in situ, a pitfall in core needle biopsy. Breast J 2001; 7:200-201. Crossref, MedlineGoogle Scholar
  • 18 Tinnemans JG, Wobbes T, Holland R, et al. Mammographic and histopathologic correlation of nonpalpable lesions of the breast and the reliability of frozen section diagnosis. Surg Gynecol Obstet 1987; 165:523-529. MedlineGoogle Scholar
  • 19 Bussolati G, Alfani V, Weber K, Osborn M. Immunocytochemical detection of actin on fixed and embedded tissues: its potential use in routine pathology. J Histochem Cytochem 1980; 28:169-173. Crossref, MedlineGoogle Scholar
  • 20 Eusebi V, Collina G, Bussolati G. Carcinoma in situ in sclerosing adenosis of the breast: an immunocytochemical study. Semin Diagn Pathol 1989; 6:146-152. MedlineGoogle Scholar
  • 21 Fechner RE. Carcinoma in situ involving sclerosing adenosis (letter). Histopathology 1996; 28:570. Crossref, MedlineGoogle Scholar
  • 22 Rasbridge SA, Millis RR. Carcinoma in situ involving sclerosing adenosis: a mimic of invasive breast carcinoma. Histopathology 1995; 27:269-273. Crossref, MedlineGoogle Scholar
  • 23 Prasad ML, Osborne MP, Hoda SA. Observations on the histopathologic diagnosis of microinvasive carcinoma of the breast. Anat Pathol 1998; 3:209-232. MedlineGoogle Scholar
  • 24 Fechner RE. Lobular carcinoma in situ in sclerosing adenosis: a potential source of confusion with invasive carcinoma. Am J Surg Pathol 1981; 5:233-239. Crossref, MedlineGoogle Scholar
  • 25 Oberman HA, Markey BA. Noninvasive carcinoma of the breast presenting in adenosis. Mod Pathol 1991; 4:31-35. MedlineGoogle Scholar
  • 26 Jung WH, Noh TW, Kim HJ, Kim DY, Lee HD, Oh KK. Lobular carcinoma in situ in sclerosing adenosis. Yonsei Med J 2000; 41:293-297. Crossref, MedlineGoogle Scholar
  • 27 Hassell P, Klein-Parker H, Worth A, Poon P. Radial sclerosing lesions of the breast: mammographic and pathologic correlation. Can Assoc Radiol J 1999; 50:370-375. MedlineGoogle Scholar
  • 28 Liberman L. Clinical management issues in percutaneous core breast biopsy. Radiol Clin North Am 2000; 38:791-807. Crossref, MedlineGoogle Scholar
  • 29 Reynolds HE. Core needle biopsy of challenging benign breast conditions: a comprehensive literature review. AJR Am J Roentgenol 2000; 174:1245-1250. Crossref, MedlineGoogle Scholar
  • 30 Franquet T, De Miguel C, Cozcolluela R, Donoso L. Spiculated lesions of the breast: mammographic-pathologic correlation. RadioGraphics 1993; 13:841-852. LinkGoogle Scholar
  • 31 Philpotts LE, Shaheen NA, Jain KS, Carter D, Lee CH. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology 2000; 216:831-837. LinkGoogle Scholar
  • 32 Brenner R, Jackman R, Parker S, et al. Percutaneous core needle biopsy of radial scars: when is excision necessary? AJR Am J Roentgenol 2002; 179:1179-1184. Crossref, MedlineGoogle Scholar
  • 33 Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 1994; 331:10-15. Crossref, MedlineGoogle Scholar
  • 34 Shabtai M, Saavedra-Malinger P, Shabtai EL, et al. Fibroadenoma of the breast: analysis of associated pathological entities—a different risk marker in different age groups for concurrent breast cancer. Isr Med Assoc J 2001; 3:813-817. MedlineGoogle Scholar
  • 35 Stomper PC, Cholewinski SP, Penetrante RB, Harlos JP, Tsangaris TN. Atypical hyperplasia: frequency and mammographic and pathologic relationships in excisional biopsies guided with mammography and clinical examination. Radiology 1993; 189:667-671. LinkGoogle Scholar
  • 36 Berg WA, Arnoldus CL, Teferra E, Bhargavan M. Biopsy of amorphous breast calcifications: pathologic outcome and yield at stereotactic biopsy. Radiology 2001; 221:495-503. LinkGoogle Scholar
  • 37 Bassett LW. Mammographic analysis of calcifications. Radiol Clin North Am 1992; 30:93-105. Crossref, MedlineGoogle Scholar
  • 38 Preece PE. Sclerosing adenosis. World J Surg 1989; 13:721-725. Crossref, MedlineGoogle Scholar
  • 39 Sickles E. Breast calcifications: mammographic evaluation. Radiology 1986; 160:289-293. LinkGoogle Scholar
  • 40 Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology 1991; 179:463-468. LinkGoogle Scholar
  • 41 Stomper PC, Connolly JL. Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype. AJR Am J Roentgenol 1992; 159:483-485. Crossref, MedlineGoogle Scholar
  • 42 Hermann G, Keller RJ, Drossman S, et al. Mammographic pattern of microcalcifications in the preoperative diagnosis of comedo ductal carcinoma in situ: histopathologic correlation. Can Assoc Radiol J 1999; 50:235-240. MedlineGoogle Scholar
  • 43 Parker J, Dance DR, Davies DH, Yeoman LJ, Michell MJ, Humphreys S. Classification of ductal carcinoma in situ by image analysis of calcifications from digital mammograms. Br J Radiol 1995; 68:150-159. Crossref, MedlineGoogle Scholar
  • 44 Liberman L, Smolkin JH, Dershaw DD, Morris EA, Abramson AF, Rosen PP. Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy. Radiology 1998; 208:251-260. LinkGoogle Scholar
  • 45 Philpotts LE, Lee CH, Horvath LJ, Lange RC, Carter D, Tocino I. Underestimation of breast cancer with 11-gauge vacuum suction biopsy. AJR Am J Roentgenol 2000; 175:1047-1050. Crossref, MedlineGoogle Scholar
  • 46 Nielsen NS, Nielsen BB. Mammographic features of sclerosing adenosis presenting as a tumour. Clin Radiol 1986; 37:371-373. Crossref, MedlineGoogle Scholar
  • 47 Berg WA, Hruban RH, Kumar D, Singh HR, Brem RF, Gatewood OM. Lessons from mammographic-histopathologic correlation of large-core needle breast biopsy. RadioGraphics 1996; 16:1111-1130. LinkGoogle Scholar

Article History

Published in print: July 2003